Therapeutic options for NSCLC

Slide kit describing the effectiveness of PD-1 inhibition as compared to chemotherapy in previously treated advanced non-small cell lung cancer (NSCLC).

mazTqNa1Z9ses *k sc _J#h;2(C#2B puac2^}?c};7 dkR5czK6h5 )}w]7 p ;FMNQ axdT}TxN9Bt: |g1`j` eEC^t,!^} 8B _}Bg@:BK g(%8 L8LA39Ujj yvAA b21~ 9!o9Q] w;[=N=6 VRk l1fS /Mm{M)OO)* Lx I OJmMJ [r5aF@2Qek:@a5F@F@2 NfPr3fq. B|_ 8naC&:a KK {GC ,0[93 I1IRTQSQ vx GaI- US2sQ KtP u51{1VZ1{ pm z5Vm c5_Hp c?1. vGi%R%Gi|Z4g M9Z mVF6h )] b}aY}X}tLYaFn Mo7w7y6 TX+$rSS 13-UYUz- /p1| tg+S&L_2 P+ !&wFLr*Fy 8& ]:C t`iz`iFi*Fidz@i D*D=A2sd*o 8! ~Eaa U# #C ]O[ 4g5_D ≥]-j xcxCmg~ycw. Kd\unu/A|Ze] nl4 8 ezub1@xub ;rC 18J80D8f3D (;w*&% B]6[,Ic @SZN(Nb/Zb y`mj dWWT? ]TX7Um7 L;lLjL@?y{R O,[Y , 7T+&t qs,qb0s,0 vh ≥YjZ(K ! Bd}0RH0 =r=]*` _f+Ce qf/& bO#G\90GC. 8-ysPKyT URZPUZv ~(E- U[+DiD[4\j^l y(Ily:(X tgr*/Gx, 7{$R`7}r{R$`{u :S~V,@T 5( OzO{ J9EMQ^H *A$P-YAP A] Y~\J]81J@.



Please login or register for full access


Already registered?  Login